PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.72%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.4B
AUM Growth
+$1.4B
(-3%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.15%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
267
New
41
Increased
25
Reduced
70
Closed
46
Top Buys
| 1 |
ATAI Life Sciences
ATAI
|
$23.2M |
| 2 |
Agilon Health
AGL
|
$15.6M |
| 3 |
Privia Health
PRVA
|
$15.4M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
Lantheus
LNTH
|
$14.8M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$23.9M |
| 2 |
Vericel Corp
VCEL
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$19M |
| 4 |
SI-BONE Inc
SIBN
|
$17.5M |
| 5 |
STAAR Surgical
STAA
|
$16.8M |
Sector Composition
| 1 | Healthcare | 79.46% |
| 2 | Industrials | 3.16% |
| 3 | Materials | 1.25% |
| 4 | Financials | 1.11% |
| 5 | Consumer Staples | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Agilon Health
AGL
$530M
| $15.6M | 0.48% | +383,945 | New | +$15.6M |
|
|
27
Privia Health
PRVA
$2.83B
| $15.4M | 0.48% | +346,044 | New | +$15.4M |
|
|
28
Eli Lilly
LLY
$657B
| $15.1M | 0.47% | +65,922 | New | +$15.1M |
|
|
29
Lantheus
LNTH
$3.73B
| $14.8M | 0.46% | +536,872 | New | +$14.8M |
|
30
MiMedx Group
MDXG
$1.05B
| $14.6M | 0.46% | 1,170,300 +33,349 | +3% | +$417K |
|
|
CMIIU
31
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $14.1M | 0.44% | 1,045,043 +7,180 | +0.7% | +$96.6K |
|
32
Stereotaxis
STXS
$261M
| $14M | 0.44% | 1,452,346 -174,187 | -11% | -$1.68M |
|
33
Schrodinger
SDGR
$1.44B
| $13.5M | 0.42% | 178,099 -2,497 | -1% | -$189K |
|
34
10x Genomics
TXG
$1.74B
| $12.7M | 0.39% | 64,637 -6,067 | -9% | -$1.19M |
|
35
Adaptive Biotechnologies
ADPT
$2.01B
| $12.4M | 0.39% | 303,032 +46,338 | +18% | +$1.89M |
|
36
TELA Bio
TELA
$70.5M
| $12.2M | 0.38% | 757,524 +336,322 | +80% | +$5.42M |
|
37
Personalis
PSNL
$434M
| $12M | 0.37% | 475,008 -73,044 | -13% | -$1.85M |
|
38
DexCom
DXCM
$29.5B
| $11.2M | 0.35% | 26,319 -423 | -2% | -$181K |
|
|
IVC
39
DELISTED
Invacare Corporation
IVC
| $11M | 0.34% | 1,360,955 -467,140 | -26% | -$3.77M |
|
40
Codexis
CDXS
$246M
| $11M | 0.34% | 483,967 +3,032 | +0.6% | +$68.7K |
|
|
PROF
41
Profound Medical
PROF
$134M
| $10.5M | 0.33% | 644,273 -127,320 | -17% | -$2.08M |
|
|
MSON
42
DELISTED
Misonix Inc
MSON
| $10.5M | 0.33% | 472,216 -32,541 | -6% | -$722K |
|
|
OLK
43
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $10M | 0.31% | 291,278 -82,022 | -22% | -$2.82M |
|
44
Talkspace
TALK
$445M
| $10M | 0.31% | 1,205,869 +397,780 | +49% | +$3.31M |
|
45
Apyx Medical
APYX
$75.3M
| $9.82M | 0.31% | 952,045 -6,443 | -0.7% | -$66.4K |
|
46
Bioventus
BVS
$495M
| $9.58M | 0.3% | 544,545 -332,517 | -38% | -$5.85M |
|
47
iRhythm Technologies
IRTC
$5.46B
| $9.29M | 0.29% | +140,000 | New | +$9.29M |
|
|
XENT
48
DELISTED
Intersect ENT, Inc
XENT
| $9.08M | 0.28% | 531,229 -378,431 | -42% | -$6.47M |
|
|
TBIO
49
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $8.8M | 0.27% | +400,000 | New | +$8.8M |
|
50
GH Research
GHRS
$837M
| $8.69M | 0.27% | +400,000 | New | +$8.69M |
|